SCM

Stonepine Capital Management Portfolio holdings

AUM $102M
This Quarter Return
-7.67%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$103M
AUM Growth
+$103M
Cap. Flow
-$28M
Cap. Flow %
-27.14%
Top 10 Hldgs %
76.67%
Holding
32
New
7
Increased
5
Reduced
14
Closed
6

Top Buys

1
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$7.55M
2
AMRN
Amarin Corp
AMRN
$4.68M
3
ENTA icon
Enanta Pharmaceuticals
ENTA
$3.87M
4
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
$2.33M
5
HTGM
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$2M

Top Sells

1
VNDA icon
Vanda Pharmaceuticals
VNDA
$18.9M
2
LGND icon
Ligand Pharmaceuticals
LGND
$13.7M
3
APEN
Apollo Endosurgery, Inc.
APEN
$3.68M
4
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
$3.44M
5
ALIM
Alimera Sciences, Inc.
ALIM
$2.09M

Sector Composition

1 Healthcare 96.27%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AMRN
1
Amarin Corp
AMRN
$314M
$18.8M 18.24%
1,239,568
+308,964
+33% +$4.68M
OXFD
2
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$11.3M 11.01%
681,812
+453,912
+199% +$7.55M
BDSI
3
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$10.9M 10.61%
2,595,855
-168,620
-6% -$710K
ENTA icon
4
Enanta Pharmaceuticals
ENTA
$192M
$7.8M 7.57%
129,867
+64,383
+98% +$3.87M
NEOS
5
DELISTED
Neos Therapeutics, Inc
NEOS
$6.66M 6.47%
4,502,301
-468,713
-9% -$694K
CPIX icon
6
Cumberland Pharmaceuticals
CPIX
$55.2M
$5.1M 4.95%
860,449
-11,313
-1% -$67.1K
APEN
7
DELISTED
Apollo Endosurgery, Inc.
APEN
$4.81M 4.67%
1,463,188
-1,117,330
-43% -$3.68M
OPNT
8
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$4.73M 4.59%
314,073
-1,395
-0.4% -$21K
XOMA icon
9
Xoma
XOMA
$420M
$4.54M 4.4%
230,201
-40,248
-15% -$793K
ISEE
10
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$4.29M 4.16%
3,825,903
-287,619
-7% -$322K
HTGM
11
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$3.85M 3.73%
5,790,269
+3,004,684
+108% +$2M
ADMS
12
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
$3.84M 3.73%
751,012
-672,566
-47% -$3.44M
CTIC
13
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$3.11M 3.02%
3,711,999
-192,401
-5% -$161K
LGND icon
14
Ligand Pharmaceuticals
LGND
$3.19B
$2.98M 2.9%
29,965
-137,522
-82% -$13.7M
NVLN
15
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$2.69M 2.61%
3,703,420
+3,212,324
+654% +$2.33M
APVO icon
16
Aptevo Therapeutics
APVO
$5.26M
$2.01M 1.95%
3,413,421
-509,470
-13% -$300K
ALIM
17
DELISTED
Alimera Sciences, Inc.
ALIM
$1.55M 1.51%
2,740,417
-3,699,081
-57% -$2.09M
CORV
18
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$1.02M 0.99%
+509,356
New +$1.02M
IDXG
19
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$922K 0.89%
1,160,378
-592,806
-34% -$471K
CHMA
20
DELISTED
Chiasma, Inc. Common Stock
CHMA
$543K 0.53%
+109,743
New +$543K
KALV icon
21
KalVista Pharmaceuticals
KALV
$719M
$383K 0.37%
+33,033
New +$383K
ACER
22
DELISTED
Acer Therapeutics Inc. Common Stock (DE)
ACER
$364K 0.35%
+114,175
New +$364K
TVTX icon
23
Travere Therapeutics
TVTX
$1.62B
$344K 0.33%
+29,675
New +$344K
AFMD
24
DELISTED
Affimed
AFMD
$231K 0.22%
78,500
-637,254
-89% -$1.88M
DRRX icon
25
DURECT Corp
DRRX
$60.2M
$184K 0.18%
+100,000
New +$184K
1
2